111 Inc
NASDAQ:YI
111 Inc
Other Items
111 Inc
Other Items Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Other Items | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
111 Inc
NASDAQ:YI
|
Other Items
¥6.2m
|
CAGR 3-Years
-73%
|
CAGR 5-Years
33%
|
CAGR 10-Years
N/A
|
|
|
D
|
DaShenLin Pharmaceutical Group Co Ltd
SSE:603233
|
Other Items
-¥50.5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
LBX Pharmacy Chain JSC
SSE:603883
|
Other Items
¥30.1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Yifeng Pharmacy Chain Co Ltd
SSE:603939
|
Other Items
¥169.4m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Yixintang Pharmaceutical Group Co Ltd
SZSE:002727
|
Other Items
-¥898.5m
|
CAGR 3-Years
-87%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-7%
|
|
|
A
|
Anhui Huaren Health Pharmaceutical Co Ltd
SZSE:301408
|
Other Items
-¥326.1m
|
CAGR 3-Years
-275%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
111 Inc
Glance View
111, Inc. engages in the provision of pharmaceutical products and medical services through online retail pharmacy and indirectly through offline pharmacy network. The company is headquartered in Shanghai, Shanghai. The company went IPO on 2018-09-12. The firm is mainly engaged in the provision of online medical services, drug purchasing and health management services through Internet and information technology. The firm mainly conducts its business in the domestic market.
See Also
What is 111 Inc's Other Items?
Other Items
6.2m
CNY
Based on the financial report for Sep 30, 2025, 111 Inc's Other Items amounts to 6.2m CNY.
What is 111 Inc's Other Items growth rate?
Other Items CAGR 5Y
33%
Over the last year, the Other Items growth was -90%. The average annual Other Items growth rates for 111 Inc have been -73% over the past three years , 33% over the past five years .
